<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CRA Team Archives - Clinical Research Services</title>
	<atom:link href="https://clinicalresearch.at/en/category/cra-team-en/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicalresearch.at/en/category/cra-team-en/</link>
	<description>Dienstleistungen im klinisch-medizinischen Bereich der Pharmaindustrie</description>
	<lastBuildDate>Thu, 20 Apr 2023 08:15:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://clinicalresearch.at/wp-content/uploads/2020/03/cropped-clinicalresearch_logo_2-32x32.jpg</url>
	<title>CRA Team Archives - Clinical Research Services</title>
	<link>https://clinicalresearch.at/en/category/cra-team-en/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>MAG. HONORATA DONNERMAIR</title>
		<link>https://clinicalresearch.at/en/mag-honorata-donnermair/</link>
					<comments>https://clinicalresearch.at/en/mag-honorata-donnermair/#respond</comments>
		
		<dc:creator><![CDATA[klubarbeit-master]]></dc:creator>
		<pubDate>Thu, 05 Mar 2020 18:47:27 +0000</pubDate>
				<category><![CDATA[CRA Team]]></category>
		<guid isPermaLink="false">http://re.clinicalresearch.at/mag-honorata-donnermair/</guid>

					<description><![CDATA[<p>Place of Home: Ried in Innkreis I’m working for CRS since: 2017 Working experience in clinical research: 8 Years Indication field and patient numbers: Traumatic brain injury (MPG) &#8211; 68 patients Traumatic brain injury (AMG) &#8211; 7 patients SAH (subarachnoid hemorrhage ) &#8211; 8 patients SAH (subarachnoid haemorrhage enteral nutritional product) &#8211; 13 patients SRSE (&#8230;</p>
<p>The post <a href="https://clinicalresearch.at/en/mag-honorata-donnermair/">MAG. HONORATA DONNERMAIR</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></description>
										<content:encoded><![CDATA[<ul>
<li><strong>Place of Home: </strong>Ried in Innkreis</li>
<li><strong>I’m working for CRS since: </strong>2017</li>
<li><strong>Working experience in clinical research: </strong>8 Years</li>
<li><strong>Indication field and patient numbers:</strong>
<ul>
<li>Traumatic brain injury (MPG) &#8211; 68 patients</li>
<li>Traumatic brain injury (AMG) &#8211; 7 patients</li>
<li>SAH (subarachnoid hemorrhage ) &#8211; 8 patients</li>
<li>SAH (subarachnoid haemorrhage enteral nutritional product) &#8211; 13 patients</li>
<li>SRSE ( Super-refractory status epilepticus) &#8211; 1 patient</li>
<li>Lung Fibrosis phase III &#8211; 150 patients</li>
<li>Oncolytic virus Phase I study, dose escalation &#8211; 117 patients</li>
<li>Crohn’s Disease phase IIa &#8211; 100 patients</li>
<li>Clinically significant portal hypertension (CSPH) Phase II &#8211; 230 patients</li>
<li>SVT Supraventricular Tachycardia in Pediatric Patients</li>
<li>COVID-19 phase II/III</li>
<li>CTBI &#8211; international register study &#8211; 120 patients</li>
<li>ICH &#8211; national register study &#8211; 270 patients</li>
<li>Acute (meningo)-encephalitis (AE)  register- 20 patients</li>
<li>Inflammatory Bowel Disease (IBD) national register &#8211; 200 patients</li>
<li>Alpha-1- Antitripsnmangel register</li>
</ul>
</li>
</ul>
<p>The post <a href="https://clinicalresearch.at/en/mag-honorata-donnermair/">MAG. HONORATA DONNERMAIR</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://clinicalresearch.at/en/mag-honorata-donnermair/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>DR. TATJANA MORY-PÖNISCH</title>
		<link>https://clinicalresearch.at/en/mag-rer-nat-teresa-hortenhuber/</link>
					<comments>https://clinicalresearch.at/en/mag-rer-nat-teresa-hortenhuber/#respond</comments>
		
		<dc:creator><![CDATA[klubarbeit-master]]></dc:creator>
		<pubDate>Thu, 05 Mar 2020 18:46:03 +0000</pubDate>
				<category><![CDATA[CRA Team]]></category>
		<guid isPermaLink="false">http://re.clinicalresearch.at/mag-rer-nat-teresa-hortenhuber/</guid>

					<description><![CDATA[<p>Place of Home: Mondsee I’m working for CRS since: 2012 Working experience in clinical research: 23 Years Indication field and patient numbers: Oncology – 1000 patients Transplantation – 500 patients Infectious diseases – 10 patients Respiratory – 50 patients Gastroenterology – 20 patients Radiology – 40 patients Medical device studies – 100 patients</p>
<p>The post <a href="https://clinicalresearch.at/en/mag-rer-nat-teresa-hortenhuber/">DR. TATJANA MORY-PÖNISCH</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></description>
										<content:encoded><![CDATA[<ul>
<li><strong>Place of Home:</strong> Mondsee</li>
<li><strong>I’m working for CRS since: </strong>2012</li>
<li><strong>Working experience in clinical research: </strong>23 Years</li>
<li><strong>Indication field and patient numbers:</strong>
<ul>
<li>Oncology – 1000 patients</li>
<li>Transplantation – 500 patients</li>
<li>Infectious diseases – 10 patients</li>
<li>Respiratory – 50 patients</li>
<li>Gastroenterology – 20 patients</li>
<li>Radiology – 40 patients</li>
<li>Medical device studies – 100 patients</li>
</ul>
</li>
</ul>
<p>The post <a href="https://clinicalresearch.at/en/mag-rer-nat-teresa-hortenhuber/">DR. TATJANA MORY-PÖNISCH</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://clinicalresearch.at/en/mag-rer-nat-teresa-hortenhuber/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MAG. RER. NAT. NICOLE ODER, MAS</title>
		<link>https://clinicalresearch.at/en/mag-rer-nat-nicole-oder-mas/</link>
					<comments>https://clinicalresearch.at/en/mag-rer-nat-nicole-oder-mas/#respond</comments>
		
		<dc:creator><![CDATA[klubarbeit-master]]></dc:creator>
		<pubDate>Thu, 05 Mar 2020 18:44:03 +0000</pubDate>
				<category><![CDATA[CRA Team]]></category>
		<guid isPermaLink="false">http://re.clinicalresearch.at/mag-rer-nat-nicole-oder-mas/</guid>

					<description><![CDATA[<p>Place of Home: Guntramsdorf I’m working for CRS since: 2010 Working experience in clinical research: 20 Years Indication field and patient numbers: Pulmonary arterial hypertension &#8211; 7 patients Colon cancer &#8211; 32 patients Pancreatic ductal adenocarcinoma &#8211; 14 patients Metastatic colorectal, gastroesophageal and renal cell carcinoma &#8211; 5 patients Acute myeloid leucaemia &#8211; 12 patients Diffuse&#8230;</p>
<p>The post <a href="https://clinicalresearch.at/en/mag-rer-nat-nicole-oder-mas/">MAG. RER. NAT. NICOLE ODER, MAS</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></description>
										<content:encoded><![CDATA[<ul>
<li><strong>Place of Home:</strong> Guntramsdorf</li>
<li><strong>I’m working for CRS since: </strong>2010</li>
<li><strong>Working experience in clinical research: </strong>20 Years</li>
<li><strong>Indication field and patient numbers:</strong>
<ul>
<li>Pulmonary arterial hypertension &#8211; 7 patients</li>
<li>Colon cancer &#8211; 32 patients</li>
<li>Pancreatic ductal adenocarcinoma &#8211; 14 patients</li>
<li>Metastatic colorectal, gastroesophageal and renal cell carcinoma &#8211; 5 patients</li>
<li>Acute myeloid leucaemia &#8211; 12 patients</li>
<li>Diffuse large B-Cell lymphoma &#8211; 16 patients</li>
<li>Chronic myelogenous leucaemia &#8211; 16 patients</li>
<li>Myelofibrosis &#8211; 9 patients</li>
<li>Gastrointestinal stromal tumor &#8211; 18 patients</li>
<li>Hepatocellular carcinoma &#8211; 18 patients</li>
<li>Multiple myeloma &#8211; 18 patients</li>
<li>Knee and hip osteoarthritis with chronic  pain &#8211; 45 patients</li>
<li>Chronic malignant tumor-related pain &#8211; 10 patients</li>
<li>Enteral nutrition in gastrointestinal  tumor patients &#8211; 205 patients</li>
<li>Malnutrient surgical patients &#8211; 60 patients</li>
<li>Breast cancer &#8211; 47 patients</li>
<li>Advanced breast cancer &#8211; 249 patients</li>
<li>Allergic rhinitis &#8211; 72 patients</li>
<li>Atrial fibrillation/atrial flutter &#8211; 20 patients</li>
<li>Heart failure &#8211; 81 patients</li>
<li>Hypercholesterolemia &#8211; 47 patients</li>
<li>Graft versus host disease &#8211; 22 patients</li>
<li>Epileptic seizure &#8211; 6 patients</li>
<li>Diabetic macular edema &#8211; 25 patients</li>
<li>COVID-19 &#8211; 209 patients</li>
<li>Essential thrombocytopenia &#8211; 10 patients</li>
</ul>
</li>
</ul>
<p>The post <a href="https://clinicalresearch.at/en/mag-rer-nat-nicole-oder-mas/">MAG. RER. NAT. NICOLE ODER, MAS</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://clinicalresearch.at/en/mag-rer-nat-nicole-oder-mas/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MAG. MARTINA GÖRNER</title>
		<link>https://clinicalresearch.at/en/martina-gorner-mag/</link>
					<comments>https://clinicalresearch.at/en/martina-gorner-mag/#respond</comments>
		
		<dc:creator><![CDATA[klubarbeit-master]]></dc:creator>
		<pubDate>Thu, 05 Mar 2020 18:43:17 +0000</pubDate>
				<category><![CDATA[CRA Team]]></category>
		<guid isPermaLink="false">http://re.clinicalresearch.at/martina-gorner-mag/</guid>

					<description><![CDATA[<p>Place of Home: Vienna I’m working for CRS since: 2004 Working experience in clinical research: 27 Years Indication field and patient numbers: Oncology – 220 patients Rheumatology – 10 patients Diabetes – 30 patients Dermatology – 50 patients Allergology – 250 patients Infectious diseases – 50 patients Respiratory – 100 patients Gastroenterology – 70 patients Urology – 50&#8230;</p>
<p>The post <a href="https://clinicalresearch.at/en/martina-gorner-mag/">MAG. MARTINA GÖRNER</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></description>
										<content:encoded><![CDATA[<ul>
<li><strong>Place of Home:</strong> Vienna</li>
<li><strong>I’m working for CRS since: </strong>2004</li>
<li><strong>Working experience in clinical research: </strong>27 Years</li>
<li><strong>Indication field and patient numbers:</strong>
<ul>
<li>Oncology – 220 patients</li>
<li>Rheumatology – 10 patients</li>
<li>Diabetes – 30 patients</li>
<li>Dermatology – 50 patients</li>
<li>Allergology – 250 patients</li>
<li>Infectious diseases – 50 patients</li>
<li>Respiratory – 100 patients</li>
<li>Gastroenterology – 70 patients</li>
<li>Urology – 50 patients</li>
<li>Clinical Pharmacology/Early Clinical Development – 30 patients</li>
</ul>
</li>
</ul>
<p>The post <a href="https://clinicalresearch.at/en/martina-gorner-mag/">MAG. MARTINA GÖRNER</a> appeared first on <a href="https://clinicalresearch.at/en/">Clinical Research Services</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://clinicalresearch.at/en/martina-gorner-mag/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
